1795 related articles for article (PubMed ID: 27142354)
1. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
[TBL] [Abstract][Full Text] [Related]
3. Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation.
Kim WK; Praz F; Blumenstein J; Liebetrau C; Gaede L; Van Linden A; Hamm C; Walther T; Windecker S; Möllmann H
Catheter Cardiovasc Interv; 2017 Jan; 89(1):E38-E43. PubMed ID: 26945934
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter aortic valve implantation for treatment of patients with degenerated aortic bioprostheses--valve-in-valve technique.
Gotzmann M; Mügge A; Bojara W
Catheter Cardiovasc Interv; 2010 Dec; 76(7):1000-6. PubMed ID: 20824744
[TBL] [Abstract][Full Text] [Related]
5. Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and results.
Bapat V; Davies W; Attia R; Hancock J; Bolter K; Young C; Redwood S; Thomas M
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):917-22; discussion 922-4. PubMed ID: 25037622
[TBL] [Abstract][Full Text] [Related]
6. Use of transcatheter heart valves for a valve-in-valve implantation in patients with degenerated aortic bioprosthesis: technical considerations and results.
Bapat V; Attia R; Redwood S; Hancock J; Wilson K; Young C; Thomas M
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1372-9; discussion 1379-80. PubMed ID: 23140962
[TBL] [Abstract][Full Text] [Related]
7. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
[TBL] [Abstract][Full Text] [Related]
8. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve.
Loyalka P; Nascimbene A; Schechter M; Petrovic M; Sundara Raman A; Gregoric ID; Kar B
Catheter Cardiovasc Interv; 2017 Jun; 89(7):1280-1285. PubMed ID: 27696659
[TBL] [Abstract][Full Text] [Related]
10. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter aortic valve-in-valve treatment of degenerative stentless supra-annular Freedom Solo valves: A single centre experience.
Cockburn J; Dooley M; Parker J; Hill A; Hutchinson N; de Belder A; Trivedi U; Hildick-Smith D
Catheter Cardiovasc Interv; 2017 Feb; 89(3):438-444. PubMed ID: 27315455
[TBL] [Abstract][Full Text] [Related]
12. Transcarotid aortic valve-in-valve implantation for degenerated stentless aortic root conduits with severe regurgitation: a case series.
Huber C; Praz F; O'Sullivan CJ; Langhammer B; Gloekler S; Stortecky S; von Allmen RS; Meier B; Carrel T; Englberger L; Windecker S; Wenaweser P
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):694-700. PubMed ID: 25776924
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of failing biological prosthesis because of "Stent creep" with valve-in-valve transcatheter aortic valve implantation.
Attia R; Papalexopoulou N; Hancock J; Young C; Thomas M; Bapat V
Catheter Cardiovasc Interv; 2015 Aug; 86(2):E119-25. PubMed ID: 24550020
[TBL] [Abstract][Full Text] [Related]
14. Successful transfemoral Edwards SAPIEN 3 valve in valve implantation in a patient with a degenerated aortic bioprosthesis associated with severe paravalvular aortic regurgitation.
Bijuklic K; Hansen L; Witt J; Schofer J
Clin Res Cardiol; 2015 Jan; 104(1):92-3. PubMed ID: 25227426
[No Abstract] [Full Text] [Related]
15. Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre.
Kaya D; Tanriverdi Z; Dursun H; Colluoglu T
Int J Cardiovasc Imaging; 2016 Sep; 32(9):1371-1378. PubMed ID: 27278270
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
García E; Martín P; Hernández R; Rodríguez V; Fernández A; Gama V; Almería C; Macaya C
Catheter Cardiovasc Interv; 2014 Apr; 83(5):791-5. PubMed ID: 24285561
[TBL] [Abstract][Full Text] [Related]
17. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
[TBL] [Abstract][Full Text] [Related]
18. Which available transapical transcatheter valve fits into degenerated aortic bioprostheses?
Ferrari E; Marcucci C; Sulzer C; von Segesser LK
Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):83-5. PubMed ID: 20395247
[TBL] [Abstract][Full Text] [Related]
19. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
[TBL] [Abstract][Full Text] [Related]
20. A prospective "oversizing" strategy of the Edwards SAPIEN bioprosthesis: results and impact on aortic regurgitation.
Samim M; Stella PR; Agostoni P; Kluin J; Ramjankhan F; Sieswerda G; Budde R; van der Linden M; Juthier F; Banfi C; Hurt C; Samim M; Hillaert M; van Herwerden L; Bertrand ME; Doevendans PA; Van Belle E
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):398-405. PubMed ID: 22377664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
